Because prostacyclin is a rather potent venodilator in vivo, we analyzed the effect of cyclooxygenase inhibition on venous tone in 14 anesthetized dogs during ganglionic and ,8-adrenergic blockade and atraumatic conditions. Effective vascular stiffness (a reciprocal of effective vascular compliance) as a variable of integrated venous tone was 0.30 + 0.01 mm Hg* kg/ml (n=35) and was augmented up to twofold by diclofenac (1, 3, and 10 mg/kg i.v.), ibuprofen (6 and 60 mg/kg), or indomethacin (5 mg/kg) parallel to augmentations in central venous pressure, while the rise in arterial pressure was less than half of the increase induced by equivenoconstrictor dosages of norepinephrine. After preconstriction by indomethacin or diclofenac, nitroglycerin (1.5 ,g/kg/min) lowered effective vascular stilfness (by 24+±2% or 23+± 5%, respectively), similarly as during preconstriction by norepinephrine (by 24 4%). Long-term cyclooxygenase inhibition (diclofenac 2 X 1 mg/kg/day for 4 days) did not modify arterial pressure, heart rate, or hematocrit levels in conscious dogs at rest, but it lowered plasma volume to 52.54±1.9 ml/kg (sham treatment: 59.1+±1.6 ml/kg, p<O.O5, n=4). In conclusion, venoconstriction by clinical dosages of cyclooxygenase inhibitors does not interfere with the venodilator action of nitroglycerin and is compensated chronically by adjustments of plasma volume. (Circulation 1988;78:407-415) 
I nhibitors of the cyclooxygenase pathway are in common clinical usage for a wide variety of symptoms. Although their principle pharmacological action is to inhibit the formation of prostaglandin-mediated inflammation,' it is known that they exhibit a variety of cardiovascular effects. Increases in arterial pressure2-7 and coronary constrictions in vivo and in vitro2-4have been described; such increases may be relevant to the use of these inhibitors in patients with concomitant cardiovascular disease. However, the full spectrum of hemodynamic effects of the cyclooxygenase inhibitors (COI) is incompletely understood. Despite the recent demonstration of the important venodilator action of prostaglandins,8 little attention has been paid to the effects of COI on venous tone. Because changes in preload are instrumental in the modulation of symptoms both in congestive heart failure and angina pectoris, any tendency toward venoconstriction by COI might have important and potentially detrimental clinical implications. Furthermore, it has been suggested that the vasodilator effects of nitrates, which are paramount to their antianginal actions,9 might be mediated by nitrate-induced vascular prostacyclin synthesis,'0'11 although this remains controversial.'213 Therefore, the aim of the present investigation was twofold: to determine whether COI with different anti-inflammatory agents results in alterations in venous compliance in vivo, and to test the hypothesis whether nitroglycerin-induced venodilation is mediated by prostaglandin synthesis.
Materials and Methods

Animals and Experimental Preparation
In all, 14 dogs of either sex, weighing kg (mean, 27+±4 kg) were used repeatedly (two or three times) in different acute protocols as listed in Table 1 , and they were used in an additional protocol with long-term pretreatment (see below) without repeating the same protocol in any dog. Intervals of at least 2 weeks were allowed between two consecutive protocols in the same dog. The protocols [5] [6] [7] required acute laparatomy in anesthesia for place-ment of occlusive snares around arteries of the splanchnic bed or the hindquarter bed (Table 1) . At the end of one of these protocols, the dogs were killed by an overdose of pentobarbital. Throughout the experimental period, the dogs were maintained on a standard diet containing 2-4 meq/kg Na+ daily with free access to tap water. They remained in a vigorous condition and were checked repeatedly for maintenance of body weight, rectal temperature, and hematocrit level. Reflexes were minimized by ganglionic blockade (10 mg/kg and 10 mg/kg/hr hexamethonium, and 0.5 mg/kg methylatropine) and,-blockade (2 mg/kg nadolol). Heparin was administered intravenously (500 units/kg initial and 250 units/kg/hr maintenance). Saline and dextran were infused continuously, both at a rate of 2.5 ml/kg/hr after an initial infusion of 10 ml/kg during an equilibration period of 45 minutes. A 4-ml/kg volume of dextran (Macrodex) was exchanged for the same volume of blood, which was stored in a water bath at 370 C.
Measurements
Arterial and venous pressure were measured with Statham P231D pressure transducers (Gould, Cleveland, Ohio) and recorded continuously on a Watanabe (Herrsching, FRG) linear recorder. Effective vascular compliance was measured as modified from Echt et al'4; the stored blood (4 ml/kg) was injected into the abdominal aorta through the femoral artery catheter at a rate of 2 ml/kg/min. After 1 minute, the same volume was withdrawn. After another minute, the withdrawal procedure was repeated and followed by reinfusion in an identical manner. Thus, the total cycle time was 11 minutes (Figure 1 Table  1 , one cycle of volume change was performed to obtain a value of effective vascular compliance of the total vascular system (see Figure 1 ). COI were infused during 15 minutes, and 10 minutes were allowed for equilibration before the compliance measurement was performed. In protocols 3 and 4, we tested whether the nitroglycerin-induced reduction in venous tone is attenuated by COI. To this end, the COI administration was preceded by norepinephrine infusions. The higher infusion rate (0.15 ,ug/kg/min) was adjusted according to pilot experiments to yield an increase in slope of the pressurevolume relation (Figure 1 ) similar to that induced by the higher dosages of COI. Compliance measurements started 5 minutes after the onset of norepinephrine or nitroglycerin infusions. Eventual contributions of redistribution of cardiac output to the observed changes in effective vascular stiffness (EVS) were investigated in protocols 5-7. In protocols 5 and 6, the dogs had occlusive snares around the truncus coeliacus and the superior and inferior mesenteric arteries, implanted by acute laparatomy. In protocol 7, an additional occlusive snare was placed around the distal aorta proximal to the bifurcation. Before the start of the protocol, the abdomen was closed by sutures. The arteries were occluded by the snares, and compliance measurement was started 3 minutes later. After 15 minutes, the snares were released, and the beds were reperfused, and 20 minutes later, the compliance was measured again. After the end of the protocols 1-4, drug infusions were discontinued, protamine sulfate was given, the catheters were removed, and the animals were allowed to recover. After completing protocols 5-7, the dogs were killed by an overdose of anesthetic.
Before their use in the terminal protocols 5-7, four of the dogs were studied in an additional protocol that included long-term treatment by diclofenac, 1 mg/kg i.m., twice daily for 4 days. These dogs were trained to lie quietly on the experimental table. One carotid artery was translocated into a cutaneous loop in each dog. This artery could be punctured transcutaneously in the conscious dogs for recording of arterial pressure and for blood withdrawal. These dogs were studied in the conscious resting state at a control day, at days 3 and 4 of sham treatment (saline i.m., twice daily for 4 days) and at days 3 and 4 of diclofenac treatment. Four hours after the last intramuscular injection, the dogs rested for 30 minutes on the table; afterward, mean arterial pressure, heart rate, arterial hematocrit level, and plasma volume were measured. The latter was determined by 10 mg Evan's blue i.v. (Sigma Chemical, Munich, FRG) and by semilogarithmic extrapolation of arterial plasma concentration at injection time from several plasma samples, analyzed photometrically at 578 nm, obtained 10-40 minutes after the injection. [12] [13] [14] [15] [16] [17] [18] hours after the final diclofenac injection, these dogs were anesthetized and prepared for measurement of compliance under ganglionic and ,Badrenergic blockade as described for protocols 1-7. Compared with the effects of norepinephrine infusion in the same model, the COI in protocols 1 and 2 caused preferential venoconstriction. At dosages causing comparable elevations of EVS, the augmentation of mean arterial pressure induced by COI was less than half that of the elevation induced by norepinephrine (Figure 2) . In other protocols with longer duration or with more traumatic manipulations, COI by indomethacin (5 mg/kg) or by diclofenac (10 mg/kg) caused comparably preferential venoconstrictions (Figure 2 ). The rise in EVS induced by the highest dose of diclofenac (10 mg/kg, protocols 3, 5, and 7, n = 14) was 87 ±7%, which is similar to the respective rise induced by 60 mg/kg ibuprofen (98 + 11%, protocol 2, n = 5) and by 0.15 ,ug/kg/min norepinephrine (95 ± 13%, protocols 3, 4, and 6, n = 17). However, the rise in mean arterial pressure induced by these dosages of the two inhibitors (34 + 2% by ibuprofen and 34 ± 5% by diclofenac) was significantly (p<0.01) less than the rise induced by high dosages of norepinephrine (73 ± 7%o).
The absolute data during norepinephrine-induced constrictions in the various protocols are shown in Table 3 , Part A, and in Figures 3 and 4 . In all protocols, the norepinephrine-induced augmentations were significant.
Nitroglycerin-Induced Venodilation
In dogs with ganglionic and p-adrenergic blockade during preconstriction by 0.15 ,ug/kg/min norepinephrine, the infusion of 1.5 gg/kg/min nitroglycerin caused significant (p<0.01) declines in EVS (from 0.55 ± 0.03 to 0.41 ± 0.02 mm Hg * kg/ml, n = 11, Part A of protocols 3 and 4), in central venous pressure (from 4.4±0.4 to 2.1±0.3 mm Hg), and in mean arterial pressure (from 148 ± 5 to 128 ± 6 mm Hg). With the same dosage of nitroglycerin after preconstriction by diclofenac, EVS was lowered to a similar degree from 0.49 ± 0.05 to 0.37±0.03 mm Hg* kg/ml ( Figure 3B ). In the dogs of protocol 3, the relative decline in EVS with nitroglycerin was 23 ±5% after preconstriction by diclofenac and 24 ± 5% under preconstriction by norepinephrine. In the parallel protocol with indomethacin (Table 3) , the nitroglycerin effect on EVS was not attenuated by COI either: a 24 ± 2% decline after indomethacin and a 24 ± 6% decline with norepinephrine. Because arterial pressure with preconstriction by norepinephrine was higher than after preconstriction by COI (Figures 2, 3, and 4) , the nitroglycerin-induced declines in arterial pressures cannot be compared directly. 
Redistribution of Cardiac Output
The effective vascular stiffness, as well as any other variable of overall venous tone in situ, can be modified substantially by changes in the distribution of cardiac output between organs with different venous compliances. In particular, any redistribution of perfusion between the splanchnic bed (a vascular bed with large volume and compliance and, hence, a large time constant for venous return) and the extrasplanchnic beds (with smaller volumes, compliances, and time constants for venous return) can affect the functional characteristics of the entire venous system without any real change in venous tone.16,17 Therefore, we compared the consequences of redistribution of cardiac output completely away from the splanchnic bed with the actions of COI or of norepinephrine in our anesthetized model under autonomic blockade (Figure 4) . Under ganglionic and ,B-adrenergic blockade, the temporal occlusion of the arteries to the splanchnic organs reversibly augmented EVS by 23 ± 7% (protocols 5 (Figure 4) . Thus, diclofenac (and norepinephrine) must have augmented venous tone mainly in the splanchnic bed, but only marginally in the extrasplanchnic bed, as is illustrated by the model shown in Figure 5 . The approximative assumptions of this model are confirmed by the observations in protocol 7. After preconstriction by diclofenac, temporal hindquarter artery occlusion (which distributes cardiac output more toward the splanchnic bed) significantly augmented overall EVS (toward the value of estimated splanchnic EVS, see Figure   5 ), while the prevention of flow to the splanchnic bed lowered EVS (Figure 6 ).
Long-term Cyclooxygenase Inhibition
Treatment by diclofenac (1 mg/kg i.m., twice daily) for 4 days did not modify heart rate, mean arterial pressure, or hematocrit level in the resting conscious dogs (n = 4). Control heart rate was 94 ± 11 beats/min, and it amounted to 107±6 and 100±5 beats/min on the last 2 days of sham treatment and of diclofenac treatment, respectively. The corresponding values for mean arterial pressure and hematocrit level were 91 ± 4, 86 ±4, and 82 2 mm Hg and 40 ± 2%, 38 ± 2%, and 40 ± 3%, respectively. However, plasma volume on the last 2 days of diclofenac treatment was 52.5±1.9 ml/kg, which was significantly (p<0.05) less than on sham treatment (59.1 ± 1.6 ml/kg). Control plasma volume was 55.8 ± 1.8 ml/kg. From 12 to 18 hours after the last diclofenac injection, these four dogs were studied during anesthesia, ganglionic and ,-adrenergic blockade, and volume infusion as described in protocols 1-7. Heart rate was 122 ± 2 beats/min; mean arterial pressure was 62 ± 1 mm Hg, which was significantly (p<0.01) lower than mean arterial pressure in these four dogs in protocols without diclofenac pretreatment; CVP was 1.0±0.1 mm Hg; and EVS was 0.49±0.01 mm Hg' kg/min, which was significantly (p<0.01) higher than in protocols without pretreatment.
Discussion
In the anesthetized dogs under autonomic blockade, COI lowered the effective vascular compliance, or in other words, it increased EVS. However, it did not attenuate the action of nitroglycerin on this variable ( Figure 3 and Table 3 ).
Effective Vascular Compliance and Venous Tone
Though the total effective vascular compliance in an intact organism mainly reflects the compliance of the venous system,'4'18' 9 measured changes in this variable do not necessarily reflect only changes in venous tone. Our recent analyses'8"l9 of the model used in the present study demonstrate that changes in mean arterial pressure, intravascular volume, and cardiac output do not affect significantly the measured changes in effective vascular compliance. Furthermore, the present protocols with splanchnic occlusion under ganglionic and fl-adrenergic blockade ( Figure 4 ) demonstrate that redistribution of cardiac output away from the splanchnic bed can at most account for only a small fraction of the increase in EVS observed during COI. Thus, other mechanisms must be largely responsible. One such mechanism could be a progressive accumulation of interstitial fluid under the influence of COI. Elevation of interstitial fluid pressure has been shown to lower the compliance of peripheral veins.20-24 After the induction of heart failure with interstitial fluid accumulation in our canine model, the elevated EVS is not lowered by nitroglycerin (at a dosage similar to that used in the present study) or by a prostacyclin analogue. 25 Similar observations have been made in patients with severe congestive heart failure23'26 unless diuretics are applied to get rid of the edema. However, in the present study, nitroglycerin rapidly and substantially lowered the EVS augmented by COI. Thus, elevated interstitial fluid pressure as a cause for the augmented stiffness after COI is excluded.
The experiments with temporal occlusion of the arterial supply to various beds (Figures 4 and 6) helped to localize the vascular bed in which most of the augmentation in venous tone must have occurred ( Figure 5 ). These simple occlusion experiments under autonomic blockade qualitatively demonstrate that the observed changes in the overall compliance of the entire venous system are mainly determined by the changes in the venous compliance of the splanchnic bed. This is exactly in agreement with more sophisticated approaches for evaluating the venous system (for review, see Hainsworth27). Furthermore, these occlusion experiments prove that the observed actions of nitroglycerin on EVS must reflect reductions in venous tone: the parallel reduction of CVP and EVS cannot be the consequence of redistribution of perfusion away from the splanchnic bed (for this would lower stiffness and augment venous pressure, see Figure   4 ) or from redistributing perfusion more toward the splanchnic bed (for this would augment stiffness without changing venous pressure, see Figure 6 ).
Based on this analysis, the following conclusions appear sound: 1) The data on EVS in the anesthetized dog demonstrate substantial venous constriction induced by COI, and this constriction occurs mainly in the veins of the splanchnic bed. By comparing the nitroglycerin-induced venodilation after COI with the control reaction to nitroglycerin starting from a similar, norepinephrine-induced venoconstriction ( Figure 2 and 
